術後の妄想は,血トリプトファンの減少に関連しているのでしょうか?
R C van der Mast1, D Fekkes, P Moleman
1Department of Psychiatry, Dijkzigt Hospital, Rotterdam, Netherlands.
Lancet (London, England)
|October 5, 1991
まとめ
手術後の妄想は,脳のトリプトファンの供給量が減少したことから生じる可能性があります. この研究では,心筋切除後の妄想を経験した患者の血トリプトファン濃度が低いことが判明し,これは解剖状態との関連を示唆しています.
科学分野:
- 神経科学は神経科学である.
- バイオケミストリー バイオケミストリー
- 心血管外科手術についてです.
背景:
- 術後の妄想症は,まだ十分に理解されていない合併症である.
- 心臓切除手術を受けた患者は,妄想症を発症するリスクがあります.
研究 の 目的:
- 心臓切除後の妄想発症におけるトリプトファンの役割を調査する.
主な方法:
- トリプトファンの血濃度および比率を測定した,心筋切開後の妄想を患った7人の患者.
- これらのレベルを8人の非妄想症の術後対照患者と比較した.
主要な成果:
- 心臓切除後の妄想を患った患者は,プラズマトリプトファンの濃度が著しく低下した.
- 血トリプトファンの比率の低下は,妄想群でも観察されました.
結論:
- 脳内のトリプトファンの供給量が低下し,これは潜在的にカタボリック状態によるもので,心筋切開後の妄想症の精神症状の根底にある可能性があります.
- トリプトファンの代謝は,心臓外科手術後の妄想を予防するための治療的標的である可能性があります.
関連する概念動画
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...

